chr17-8887116-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001142633.3(PIK3R5):​c.1885C>T​(p.Pro629Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00152 in 1,614,038 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0079 ( 17 hom., cov: 32)
Exomes 𝑓: 0.00086 ( 13 hom. )

Consequence

PIK3R5
NM_001142633.3 missense

Scores

1
5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:2

Conservation

PhyloP100: 6.31

Publications

12 publications found
Variant links:
Genes affected
PIK3R5 (HGNC:30035): (phosphoinositide-3-kinase regulatory subunit 5) Phosphatidylinositol 3-kinases (PI3Ks) phosphorylate the inositol ring of phosphatidylinositol at the 3-prime position, and play important roles in cell growth, proliferation, differentiation, motility, survival and intracellular trafficking. The PI3Ks are divided into three classes: I, II and III, and only the class I PI3Ks are involved in oncogenesis. This gene encodes the 101 kD regulatory subunit of the class I PI3K gamma complex, which is a dimeric enzyme, consisting of a 110 kD catalytic subunit gamma and a regulatory subunit of either 55, 87 or 101 kD. This protein recruits the catalytic subunit from the cytosol to the plasma membrane through high-affinity interaction with G-beta-gamma proteins. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been found. [provided by RefSeq, Oct 2011]
PIK3R5 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008457243).
BP6
Variant 17-8887116-G-A is Benign according to our data. Variant chr17-8887116-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 48651.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00791 (1205/152308) while in subpopulation AFR AF = 0.0267 (1110/41560). AF 95% confidence interval is 0.0254. There are 17 homozygotes in GnomAd4. There are 574 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3R5NM_001142633.3 linkc.1885C>T p.Pro629Ser missense_variant Exon 12 of 19 ENST00000447110.6 NP_001136105.1 Q8WYR1-1L7RT34

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3R5ENST00000447110.6 linkc.1885C>T p.Pro629Ser missense_variant Exon 12 of 19 5 NM_001142633.3 ENSP00000392812.1 Q8WYR1-1

Frequencies

GnomAD3 genomes
AF:
0.00790
AC:
1203
AN:
152190
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0267
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00226
AC:
568
AN:
250856
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.0292
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.000980
GnomAD4 exome
AF:
0.000859
AC:
1256
AN:
1461730
Hom.:
13
Cov.:
32
AF XY:
0.000719
AC XY:
523
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.0278
AC:
931
AN:
33480
American (AMR)
AF:
0.00242
AC:
108
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53326
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000612
AC:
68
AN:
1111976
Other (OTH)
AF:
0.00232
AC:
140
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00791
AC:
1205
AN:
152308
Hom.:
17
Cov.:
32
AF XY:
0.00771
AC XY:
574
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0267
AC:
1110
AN:
41560
American (AMR)
AF:
0.00425
AC:
65
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68024
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
63
127
190
254
317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00264
Hom.:
5
Bravo
AF:
0.00916
ESP6500AA
AF:
0.0263
AC:
116
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00263
AC:
319
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ataxia with oculomotor apraxia type 3 Pathogenic:1Uncertain:3
May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2012
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:curation

NM_001142633.2:c.1885C>T in the PIK3R5 gene has an allele frequency of 0.029 in African subpopulation in the gnomAD database. This variant has been detected in a consanguineous family with autosomal recessive ataxias, segregating with phenotypes (PMID: 22065524). We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: BS1, PP1, PP4. -

Apr 03, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:2
Oct 28, 2020
H3Africa Consortium
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.051, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. -

Apr 09, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PIK3R5 c.1885C>T (p.Pro629Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0023 in 250856 control chromosomes, predominantly at a frequency of 0.029 within the African or African-American subpopulation in the gnomAD database, including 7 homozygotes, strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.1885C>T has been reported in the literature in individuals affected with Ataxia With Oculomotor Apraxia, unspecified disease conditions and healthy donors (example, AlTassan_2012, Capalbo_2019). These report(s) do not provide unequivocal conclusions about association of the variant with Ataxia With Oculomotor Apraxia Type 3. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22065524, 31589614). ClinVar contains an entry for this variant (Variation ID: 48651). Based on the evidence outlined above, the variant was classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Benign
0.94
DEOGEN2
Uncertain
0.46
T;.;.;.;T;.
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.84
T;.;.;T;.;T
MetaRNN
Benign
0.0085
T;T;T;T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
1.8
L;.;.;.;L;.
PhyloP100
6.3
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-2.3
N;.;.;.;.;.
REVEL
Uncertain
0.43
Sift
Benign
0.36
T;.;.;.;.;.
Sift4G
Benign
0.14
T;T;T;T;T;T
Polyphen
0.92
P;.;.;.;P;.
Vest4
0.57
MVP
0.36
MPC
1.0
ClinPred
0.054
T
GERP RS
4.7
Varity_R
0.19
gMVP
0.73
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61761068; hg19: chr17-8790433; API